2009
DOI: 10.1111/j.1538-7836.2009.03487.x
|View full text |Cite
|
Sign up to set email alerts
|

Major bleeding events in stable outpatients with coronary, cerebrovascular or peripheral artery disease: findings from the FRENA registry

Abstract: To cite this article: Gadelha T, Bisbe J, Toril J, Alcalá Pedrajas JN, Monreal M, the FRENA Investigators. Major bleeding events in stable outpatients with coronary, cerebrovascular or peripheral artery disease: findings from the FRENA registry.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2010
2010
2012
2012

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 11 publications
(14 reference statements)
0
1
0
Order By: Relevance
“…The FRENA (Factores de Riesgo y ENfermedad Arterial) Registry is an ongoing, multi-centre, observational registry designed to gather and analyse data on treatment patterns and outcomes in stable outpatients with symptomatic coronary artery disease, cerebrovascular disease or peripheral artery disease in Spanish hospitals [14][15][16]. The aim of this study was to compare the incidence of subsequent ischaemic events (myocardial infarction, ischaemic stroke or critical limb ischaemia) in patients with Type 2 diabetes and mean HbA 1c levels < 7.0% (< 53 mmol ⁄ mol) vs. those with mean HbA 1c levels > 7.0% (> 53 mmol ⁄ mol).…”
Section: Introductionmentioning
confidence: 99%
“…The FRENA (Factores de Riesgo y ENfermedad Arterial) Registry is an ongoing, multi-centre, observational registry designed to gather and analyse data on treatment patterns and outcomes in stable outpatients with symptomatic coronary artery disease, cerebrovascular disease or peripheral artery disease in Spanish hospitals [14][15][16]. The aim of this study was to compare the incidence of subsequent ischaemic events (myocardial infarction, ischaemic stroke or critical limb ischaemia) in patients with Type 2 diabetes and mean HbA 1c levels < 7.0% (< 53 mmol ⁄ mol) vs. those with mean HbA 1c levels > 7.0% (> 53 mmol ⁄ mol).…”
Section: Introductionmentioning
confidence: 99%